Cliff Asness’s Takeda Pharmaceutical TAK Stock Holding History

Cliff Asness’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.5M	Buy	1,525,686 +631,263	+71%	+$10.4M	0.01%	1093
2026 Q1	$16.6M	Buy	894,423 +215,146	+32%	+$3.78M	0.01%	1105
2025 Q4	$10.6M	Sell	679,277 -87,007	-11%	-$1.24M	0.01%	1188
2025 Q3	$11.2M	Buy	766,284 +397,142	+108%	+$5.9M	0.01%	1047
2025 Q2	$5.71M	Buy	369,142 +173,402	+89%	+$2.56M	﹤0.01%	1208
2025 Q1	$2.91M	Buy	195,740 +59,442	+44%	+$833K	﹤0.01%	1406
2024 Q4	$1.8M	Sell	136,298 -10,372	-7%	-$142K	﹤0.01%	1585
2024 Q3	$2.09M	Buy	146,670 +56,657	+63%	+$804K	﹤0.01%	1490
2024 Q2	$1.16M	Buy	90,013 +54,539	+154%	+$722K	﹤0.01%	1685
2024 Q1	$493K	Buy	+35,474	New	+$516K	﹤0.01%	1964

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Cliff Asness's TAK Position: Q2 2026 in Review

Cliff Asness increased its Takeda Pharmaceutical (TAK) stake by 71% in Q2 2026, buying an estimated $10.4M and bringing the position to 1,525,686 shares worth $24.5M. The position accounts for 0.01% of the portfolio, ranked #1093.

Cliff Asness first reported a position in TAK in Q1 2024 and has held it in 10 quarters since. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Cliff Asness held 1,525,686 shares of Takeda Pharmaceutical worth $24.5M as of Q2 2026.
Cliff Asness bought 631,263 Takeda Pharmaceutical shares in Q2 2026, an estimated $10.4M.
Takeda Pharmaceutical made up 0.01% of Cliff Asness's portfolio in Q2 2026, its #1093 holding.
Cliff Asness first reported a position in Takeda Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.